Decision Resources is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.
Related Reports Special Report: Newly Competitive Gaucher’s Disease Marketplace Showcases Strategies for Rare Diseases SPECIAL REPORT: Dealmaking and Industry Outlook in Niche Metabolic Diseases Executing Change: Survival Strategies of Big Biotech
See which reports have been searched on the most.
August 31, 2010
An Expanding Aging Population and Increases in Diagnosis and Drug Treatment Will Fuel Steady 4.6 Percent Annual Growth in the Chronic Obstructive Pulmonary Drug Market
August 30, 2010
For Treatment of Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia, 41 Percent of Surveyed European Hematologist-Oncologists Say MabThera’s Favorable Efficacy Profile is the Most Significant Driver of their Use of This Agent
August 25, 2010
Through 2019, Increased Generic Erosion of Key Agents Such as Lamictal and Depakote/Depakote ER Will Cause a Precipitous $2.3 Billion Decline in the Bipolar Disorder Drug Market
Alzheimer's Disease (Event Driven)
Last Updated 2 September 2010Despite a large and rapidly growing patient population, the treatment of... Read More
Fibromyalgia (Event Driven)
Last Updated 2 September 2010 Fibromyalgia affects an estimated 16 million people across the major... Read More
Asthma (Event Driven)
Last Updated 2 September 2010With a large and growing patient population, the asthma market is one of the... Read More